Disc Medicine Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +4.0% | +323.1% | -90.0% | -18.2% | +122.2% | +325.0% | +2.4% | +2.3% | +0.0% | +1.1% | – | |
| – | +51.7% | +110.6% | +0.8% | +5.9% | +0.0% | +46.8% | +32.3% | +13.0% | +5.6% | +18.9% | +16.8% | – | |
| – | -15.2% | -308.3% | – | +2.8% | -138.2% | – | – | +2,136.4% | +32.6% | -219.4% | – | – | |
| – | -93.3% | +2,133.3% | -95.5% | +166.7% | +5,512.5% | +89.5% | -95.8% | -27.8% | -23.1% | -100.0% | – | – | |
| – | -93.3% | +2,133.3% | +327,883.6% | -67.6% | -98.0% | +19,018.7% | – | -4.2% | -549.9% | – | -62.9% | – | |
| – | +1,586.5% | +104.9% | +989.3% | -99.8% | +6,659.9% | +748.2% | -99.6% | +1,199.1% | +1,769.8% | -99.2% | +1,805.4% | – | |
| – | – | – | – | – | – | – | – | +185.8% | -546.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.